Prostate cancer is a common type of cancer in males, but it is highly treatable in the early stages. It begins in the prostate gland, which sits between the penis and the bladder. Experts do not ...

Because of the large impact of prostate cancer, there is great interest in new methods of prevention and treatment; some of these appear to reduce mortality. [4] Lycopene is a natural product that ...

Insights from AUA 2025, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer may affect patients. AUA 2025: Previewing Updates in Metastatic ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Leg pain with prostate cancer may be a sign that cancer has spread to other parts of the body. Prostate cancer may cause leg pain if the disease spreads to the lymph nodes around the groin or bones.

Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer. Metastatic means the cancer has spread from the prostate to other parts of the body, like the bones, ...

Prostate cancer is one of the most common cancers affecting men globally, with African men facing a disproportionate burden of the disease. In Nigeria, prostate cancer has emerged as a leading ...

A new spit test for prostate cancer which can be done at home may be better than current testing methods, a study suggests. Experts have developed a simple saliva test which analyses genetic ...

Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.